Ann Wouters

The Safety and Immunogenicity of Live Zoster Vaccination in Patients With Rheumatoid Arthritis Before Starting Tofacitinib: A Randomized Phase II Trial

Kevin Winthrop, Ann Wouters, Ernest Choy et al. · Arthritis & Rheumatology · 2017 · 123 citations · Full text

Veterinary Medicine, Immunology, Pharmacotherapy +17

A phase 2 open-label safety and immunogenicity study of a meningococcal B bivalent rLP2086 vaccine in healthy adults

Helen Marshall, Peter Richmond, Michael D. Nissen et al. · Vaccine · 2013 · 81 citations

Veterinary Medicine, Immunology, Infectious Diseases +17

Reversibility of peripheral blood leukocyte phenotypic and functional changes after exposure to and withdrawal from tofacitinib, a Janus kinase inhibitor, in healthy volunteers

Kent J. Weinhold, Jack F. Bukowski, Todd V. Brennan et al. · Clinical Immunology · 2018 · 32 citations · Full text

Life Sciences, Immunology, Pharmacology +15

Assessment of the Effects of Inhibition or Induction of CYP2C19 and CYP2C9 Enzymes, or Inhibition of OAT3, on the Pharmacokinetics of Abrocitinib and Its Metabolites in Healthy Individuals

Xiaoxing Wang, Martin E. Dowty, Ann Wouters et al. · European Journal of Drug Metabolism and Pharmacokinetics · 2022 · 27 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +13

Safety and efficacy of tofacitinib for the treatment of patients with juvenile idiopathic arthritis: preliminary results of an open-label, long-term extension study

Hermine I. Brunner, Jonathan Akikusa, Eslam Al‐Abadi et al. · Annals of the Rheumatic Diseases · 2024 · 22 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +6